In a surprising move, Rentschler Biopharma announced its decision to withdraw from the cell and gene therapy (CGT) business at its Stevenage, UK facility, marking a significant shift in the company's strategic focus. This decision comes despite recent investments in building advanced capabilities
A recent study conducted by researchers at NYU Langone Health has reexamined the purported link between a mother’s health during pregnancy and the likelihood of her child developing autism. This study disputes previous assertions that maternal health conditions during pregnancy contribute directly
The groundbreaking research conducted by Van Andel Institute scientists sheds new light on how developmental epigenetic changes can profoundly influence cancer risk later in life. The study, published in Nature Cancer, identifies two distinct epigenetic states formed during development, which are
The NHS BRCA Testing Program launched in January 2023 has been a significant success in England, offering free genetic testing to individuals with Jewish ancestry to identify their risk of inherited cancers. This initiative targets people aged 18 or over with at least one Jewish grandparent, and it
Genetic testing for Lynch Syndrome (LS) is crucial in preventing certain cancers, especially for women diagnosed with endometrial (womb) cancer. This inherited condition significantly raises the lifetime risk of various cancers, including bowel, ovarian, pancreatic, and womb cancers. Despite
In today's rapidly evolving scientific landscape, groundbreaking innovations are consistently transforming our understanding of the world and pushing the boundaries of what is possible. From space exploration to bioengineering, researchers are uncovering new knowledge and developing technologies